A Brand New Network
for Allogeneic Cell
Welcome to the Allogeneic Cell Therapy: Searchlight network
Built by the cell therapy community for the cell therapy community
Membership allows strategic leaders to plug into a ready-made allo-specific network of peers to work with in a facilitated, structured but boundaryless way throughout the year to access vital new thinking, identify critical short cuts and avoid costly mistakes, providing vital insights into allogeneic next practice before it becomes best practice and to help overcome shared capacity, durability, efficacy and regulatory challenges.
Don’t miss out on the opportunity to be part of these critical conversations…
"Effectively scaling up the manufacturing of allogeneic drug products"
"Enhancing cell potency without increasing toxicity"
"Creating durable and persistent allogeneic therapies"
Join your peers today and be part of a global community of like-minded individuals
For more information on what’s included as part of the Allogeneic Cell Therapy: Searchlight membership, please download the membership brochure.
Here’s what you’ll learn more about:
- The unique mission and purpose of the network
- What membership includes
- How the quarterly cornerstone meetings work
- How bespoke value delivery works
- How we deliver demonstrable value to you
- Annual member investment
The feedback from members speaks for itself…
For more reviews about Allogeneic Cell Therapy: Searchlight membership, head to our testimonials page. and hear directly from our members about why they've joined.
Discover how we can provide you with demonstrable value…
Save time and money
Access timely insights to allow faster access to the clinic and increase your chances of success once you get there
Make valuable connections
Plug into a collaborative network sharing the full range of non-competitive ways to overcome common challenges
Amplify the allo network
Whitepaper outputs will amplify member positions to an audiences of regulators, suppliers, partners and more
Who qualifies for Searchlight: Allogeneic Cell Therapy?
Strategic allo leaders
Motivated to share
In sight of the clinic
Member companies are represented by one internal champion who has strategic oversight over its allogeneic program
Members will require a collaborative mindset, focused on what can be shared rather than being defined by what can’t
Members will be curated based on development stage (with those either in or close to reaching the clinic having priority)